Abstract:Background: Non-small cell lung cancer (NSCLC) is the most common histological type of lung cancer, and one of the malignant tumor with the highest mortality. As the main part of the optical molecular imaging probe, peptide can realize the early screening and diagnosis of tumor and improve the survival rate of patients. The aim of this study was to screen the small-molecule peptide that highly binds to NSCLC NCI-H1299 cells using in vivo phage display technology and to identify their binding specificity by in vitro experiment. Methods: To prepare a tumor-bearing nude mouse model of NCI-H1299 cells, after 3 rounds of in vivo screening with Ph.D.-C7CTM Peptide Library, phage clones were randomly picked, using immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) to identify the affinity of phage clones to NCI-H1299 cells. The positive monoclonal phages DNA was extracted and sequenced to obtain the amino acid sequence of the peptides. The peptides with the highest repetition rate was chemically synthesized and labeled with fluorescein (FITC) to prepare optical molecular probe. We preliminary identified the specificity of the probe binding to lung cancer cells by in vitro experiment. Results: After three rounds of in vivo screening, the phages enrichment rate was 341.3 times compared with the first round. Immunohistochemical staining showed that with the increase of screening times, the phages binding to tumor tissues continued to increase, and the binding amount was significantly higher than normal tissues; ELISA results showed that 20 clones among the 30 randomly selected phage clones were positive. After sequencing, the peptide with the highest repetition rate was synthesized and named NSP1; Methyl thiazolyl tetrazolium assay (MTT) and would healing assay showed that NSP1 will not affect cell proliferation and migration. Flow cytometry and immunofluorescence showed specific binding of NSP1 to NCI-H1299 cells. Conclusions: We successfully obtained the peptide NSP1 that specifically binds to lung cancer NCI-H1299 cells by in vivo phage display, which provide a theoretical basis for NSCLC early diagnosis and targeted therapy.

Research on Screening Peptides Specifically Targeting Laryngeal Squamous Cell Carcinoma by Phage Display Technique

Screening and Identification of A Targeting Peptide to Hepatocarcinoma from A Phage Display Peptide Library

[Phage Display Random Peptide Library for Screening the Peptides That Specifically Bind to Hepatocellular Carcinoma Cells].

Screening and identification of hepatocellular carcinoma cell specific binding peptides using phage display peptide library

Screening and Identification of a Specific Peptide Binding to Hepatocellular Carcinoma Cells from a Phage Display Peptide Library

Screening and Identification of Polypeptides Specifically Binding to Hepatoma Carcinoma Cells

Selection and Preliminary Identification of Hepatocarcinoma-Binding and Internalizing Peptide

Screening and Characterization of Multi-Peptide Binding Specifically to Hepatocellular Carcinoma Cells by Phage Peptide Library

Selection of the Peptides Specifically Binding to Hepatoma by Using Phage Display in Vivo

In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library.

Screening of Human Phage Antibodies with Single-Chain Variable Fragment and Identiflication of Its Specificity to Liver Cancer Cells

Targeted Drug Delivery to Hepatocarcinoma in Vivo by Phage-Displayed Specific Binding Peptide.

Identification and Localization of Hepatocarcinoma-Specific Adhesion Peptide

Screening of Proteins Binding with Human CD8+T Lymphocytes with T7 Select Human Hepatoma cDNA Library

Screening and identification of a specific peptide for targeting hypoxic hepatoma cells

Phage Display Selection of Peptides That Inhibit Metastasis Ability of Gastric Cancer Cells with High Liver-Metastatic Potential.

Screening for serum binding proteins in subjects with primary hepatocellular carcinoma using a phage display system

[Screening and Identification of the Peptides Specifically Binding to Human Non-small Cell Lung Cancer NCI-H1299 Cells]

Screening and Characterization of Multipeptide Binding Specifically to Gastric Cancer Cells by Phage Peptide Library

Screening of a specific peptide binding to esophageal squamous carcinoma cells from phage displayed peptide library.

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library